A diabetic patient presented with furunculoid lesions at the sites of insulin injections. These lesions were diagnosed as representing a manifestation of a cutaneous reaction to the zinc component of an intermediate-acting insulin. The differential diagnosis of furunculoid lesions in insulin-dependent diabetic subjects is discussed.